Keyword: Relay Therapeutics

Relay Therapeutics

Because proteins move constantly inside cells, Relay’s A-list founders and investor Third Rock Ventures think showing motion will reveal new ways to treat diseases. The first step is to go after the many frequently mutated oncogenes the industry is yet to drug.

FierceBiotech's 2017 Fierce 15

The philosophy of Fierce 15 is a simple one: We want to see the best science combined with the brightest teams, and we want to see the promise that they hold in their hands has a genuine chance of being the Next Big Thing. Here are this year's standouts.